DNA encoding a human 5-HT.sub.1F receptor, vectors, and host cells
AssigneeSynaptic Pharmaceutical Corporation
InventorsRichard L. Weinshank, Theresa Branchek, Paul R. Hartig
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptic Pharmaceutical Corporation
InventorsRichard L. Weinshank, Theresa Branchek, Paul R. Hartig
Estimating the term…
This invention provides an isolated nucleic acid molecule encoding a human 5-HT.sub.1F receptor, an isolated protein which is a human 5-HT.sub.1F receptor, vectors comprising an isolated nucleic acid molecule encoding a human 5-HT.sub.1F receptors, mammalian cells comprising such vectors, antibodies directed to the human 5-HT.sub.1F receptor, nucleic acid probes useful for detecting nucleic acid encoding human 5-HT.sub.1F receptors, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human 5-HT.sub.1F receptor, pharmaceutical compounds related to human 5-HT.sub.1F receptors, and nonhuman transgenic animals which express DNA a normal or a mutant human 5-HT.sub.1F receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT.sub.1F receptor.
An isolated nucleic acid molecule encoding a human 5-HT.sub.1F receptor having the coding sequence shown in FIGS. 1A-1C.
Dependencies are inferred from the claim text.